Global CSR Program | Takeda Pharmaceuticals
Global CSR Program
Transforming health outcomes by investing in resilient health systems worldwide
Takeda’s Global Corporate Social Responsibility (CSR) Program is a signature initiative of our philanthropic giving, which supports solutions that strengthen the resiliency of health systems in low and middle-income countries (LMICs). This program is unique in that we empower our 50,000 employees around the globe to participate in the selection of new partners each year through a worldwide vote. The vote ensures that our community of long-term partnerships reflects the priorities and preferences of all our colleagues.
Our giving is focused on addressing the impacts of climate change on health through three key pillars: reliable health infrastructure, climate-smart workforce education, and technology innovation and solutions to enhance diagnosis and treatment for climate-vulnerable populations. See below for information about our partners.
To learn more about our broader philanthropic giving approach, please visit our CSR Partnerships page.
FY2024 Programs
We were pleased to announce our newest Global CSR Program awardees at a virtual event: "Sustain, Empower, Transform; Partnering to build resilient health system worldwide."
This virtual event featured remarks from our Chief Global Corporate Affairs & Sustainability Officer Takako Ohyabu, followed by a discussion between Lesile Mancuso, President and CEO, Jhpiego, Manasseh Wandera, Executive Director, Society for Family Health (SFH), Rwanda, and David Nicholson, Chief Climate Officer, Mercy Corps.
Watch the Global CSR Program 2024 web event here.